"Ultimately, we know that as much as has been done, there is a lot of need for new treatments… and new hope. The Life Sciences Consortium is a powerful group that we can leverage. If companies and organizations come together in a collaborative way, then we can move the ball down the field a lot faster on oncology research."
Christopher A. Viehbacher
Chairman, CEO Roundtable on Cancer
Access to standardized legal language for Key elements can increase the efficiency of contract negotiations, resulting in reduced costs and accelerating the entry of new therapies into clinical trials.
The Project Data Sphere platform provides one place where the research community can broadly share, integrate and analyze historical, patient-level, comparator-arm data from academic and industry phase III cancer clinical trials.